SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-066403
Filing Date
2023-08-14
Accepted
2023-08-11 21:31:35
Documents
5
Effectiveness Date
2023-08-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea183291-s8_nektarthera.htm S-8 60092
2 OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES ea183291ex5-1_nektarthera.htm EX-5.1 7152
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea183291ex23-1_nektarthera.htm EX-23.1 2046
4 FILING FEE TABLE ea183291ex-fee_nektarthera.htm EX-FILING FEES 20202
5 GRAPHIC ex5-1_001.jpg GRAPHIC 37025
  Complete submission text file 0001213900-23-066403.txt   141830
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273962 | Film No.: 231165905
SIC: 2834 Pharmaceutical Preparations